Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754207 · ClinicalTrials.gov registry record · NA
Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
A NA study of Tattoos, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01754207 is a NA study of Tattoos that has completed, run by Cynosure. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01754207, a NA study of Tattoos, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.
Conditions Studied
Interventions
- DEVICE 755nm Alexandrite Laser
- DEVICE 755nm Alexandrite Laser with CAP Array
Study Locations (1)
Massachusetts
- Skin Care Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01754207
The ClinicalTrials.gov registry entry for NCT01754207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tattoos appearing as the primary indexed condition, and to 2 interventions - of which 755nm Alexandrite Laser is the first listed.
NCT01754207 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01754207 about?
NCT01754207 is a clinical study titled "Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos". The purpose of this study is to collect further data on the safety and efficacy of removing unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.
What is the current status of trial NCT01754207?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-12. Estimated completion is 2014-01.
What conditions does trial NCT01754207 study?
This clinical trial studies the following conditions: Tattoos.
What interventions are being tested in trial NCT01754207?
The interventions under investigation include: 755nm Alexandrite Laser (DEVICE), 755nm Alexandrite Laser with CAP Array (DEVICE).
Who is sponsoring clinical trial NCT01754207?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01754207 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.